Intranasal corticosteroid
Pregnancy: Considered safe at low doses. Minimal systemic absorption at standard doses.
Budesonide Nasal Spray
Brand names: Rhinocort Aqua, Benacort
Adult dose
Dose: 256 micrograms (2 sprays each nostril) once daily; or 128 micrograms (1 spray each nostril) twice daily
Route: Intranasal
Frequency: Once daily (morning)
Max: 256 micrograms/day (standard); 400 micrograms/day (severe AR)
Allergic rhinitis (AR): 256 mcg OD (2 sprays per nostril). Once symptoms controlled, reduce to 128 mcg/day (minimum effective dose). Nasal polyps: 256 mcg per nostril OD. Take 15 min before exposure to allergen if seasonal.
Paediatric dose
Route: Intranasal
Frequency: Once daily
Max: 128 micrograms/day (children <12 years)
6–11 years: 64–128 mcg/day (1 spray per nostril OD). ≥12 years: adult dose. Mometasone (Nasonex) or fluticasone (Flixonase) often preferred in children (less bioavailability). Use lowest effective dose.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Use with caution in severe hepatic impairment; increased systemic absorption.
Clinical pearls
- Correct technique: tilt head forward, aim away from nasal septum (toward outer nostril wall)
- Onset of action: 2–3 days minimum; full effect: 1–2 weeks — patient must persist
- Preferred over antihistamines for moderate-severe persistent allergic rhinitis
- Mometasone has lowest bioavailability (<1%) — safest in children and for long-term use
- Combine with oral antihistamine for severe seasonal AR or if eye symptoms
Contraindications
- Hypersensitivity to budesonide
- Recent nasal surgery (until healed)
Side effects
- Nasal irritation and stinging
- Epistaxis (nasal bleeding)
- Headache
- Nasopharyngitis
- Nasal septal perforation (rare — if incorrectly aimed)
- HPA axis suppression (rare — with very high doses or nasal polyp doses)
Interactions
- Ketoconazole and strong CYP3A4 inhibitors — increased systemic absorption of budesonide
Monitoring
- Symptom control
- Nasal mucosa inspection (epistaxis)
- Height (children on high-dose prolonged treatment)
Reference: BNFc; BNF; ARIA Guidelines; BSACI Allergic Rhinitis Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020